1. Immunology/Inflammation Apoptosis Anti-infection Metabolic Enzyme/Protease
  2. COX Apoptosis Influenza Virus Endogenous Metabolite
  3. Catechin

Catechin  (Synonyms: (+)-Catechin; Cianidanol; Catechuic acid)

Cat. No.: HY-N0898 Purity: 99.30%
Handling Instructions Technical Support

Catechin ((+)-Catechin) inhibits cyclooxygenase-1 (COX-1) with an IC50 of 1.4 μM.

For research use only. We do not sell to patients.

CAS No. : 154-23-4

Size Price Stock Quantity
Free Sample (0.1 - 0.2 mg)   Apply Now  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
5 mg In-stock
10 mg In-stock
50 mg In-stock
100 mg In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 20 publication(s) in Google Scholar

Other Forms of Catechin:

Top Publications Citing Use of Products

    Catechin purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2024 Dec 26;15(12):932.  [Abstract]

    Cell viability assay of PC cells treated with Y-39983, Catechin (1-100 μM; 24 h), and avatrombopag, respectively.

    Catechin purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2024 Dec 26;15(12):932.  [Abstract]

    Catechin (40 mg/kg; ip; twice a week ) in Six-week-old female BALB/c nude mice (PC cells) decreased tumors in all mice.

    Catechin purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2024 Dec 26;15(12):932.  [Abstract]

    The organs (heart, liver, lungs, and kidneys) obtained from the indicated mice were used for H&E staining. Catechin (40 mg/kg; ip; twice a week ) in Six-week-old female BALB/c nude mice (PC cells).

    Catechin purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2024 Dec 26;15(12):932.  [Abstract]

    The tumor slices were subjected to IHC staining for Ki-67 and cleaved caspase 3 levels detection and TUNEL assay. Catechin (40 mg/kg; ip; twice a week ) in Six-week-old female BALB/c nude mice (PC cells).

    Catechin purchased from MedChemExpress. Usage Cited in: Toxicol Appl Pharmacol. 2024 Jul 14:490:117036.  [Abstract]

    (A-B) CCK-8 test was employed to determine the rate at which various doses of Catechin (0, 80, 160, 240, 320, and 400 μmol/L; 24 h) inhibited the growth of gastric cancer cells. (C & D) CCK-8 test was utilized to measure the capacity of gastric cancer cells treated with various catechin doses to proliferate.

    Catechin purchased from MedChemExpress. Usage Cited in: Toxicol Appl Pharmacol. 2024 Jul 14:490:117036.  [Abstract]

    Catechin (60, 90, 120 μM; 24 h) increased the apoptosis rate of SGC-7901 cells in a dose-dependent manner.

    Catechin purchased from MedChemExpress. Usage Cited in: Toxicol Appl Pharmacol. 2024 Jul 14:490:117036.  [Abstract]

    (A-D) Wound-healing assay was used to detect the migration rate of gastric cancer cells at 24, 48, and 72 h after treatment with Catechin (60, 90, 120 μM) in SGC-7901 and MGC-803 cells.

    Catechin purchased from MedChemExpress. Usage Cited in: Toxicol Appl Pharmacol. 2024 Jul 14:490:117036.  [Abstract]

    Catechin (60, 90, 120 μM; 24 h) in SGC-7901 cells decreased the expression levels of total AKT, p-AKT, and PI3K. Western blot assay was used to detect the protein expression levels of AKT, p-AKT, PI3K and p-AKT/AKT in the PI3K/Akt pathway.

    View All COX Isoform Specific Products:

    View All Endogenous Metabolite Isoform Specific Products:

    • Biological Activity

    • Protocol

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Catechin ((+)-Catechin) inhibits cyclooxygenase-1 (COX-1) with an IC50 of 1.4 μM.

    IC50 & Target[1]

    COX-1

    1.4 μM (IC50)

    Cellular Effect
    Cell Line Type Value Description References
    A2780 IC50
    > 10 μg/mL
    Compound: page 1629, R25C1
    Cytotoxicity against human A2780 cells after 96 hrs by MTT assay
    Cytotoxicity against human A2780 cells after 96 hrs by MTT assay
    [PMID: 17125236]
    A549 ED50
    > 10 μg/mL
    Compound: 46
    Cytotoxicity against human A549 cells by tetrazolium salt-based colorimetric assay
    Cytotoxicity against human A549 cells by tetrazolium salt-based colorimetric assay
    [PMID: 1431932]
    A549 IC50
    > 10 μg/mL
    Compound: page 1629, R25C1
    Cytotoxicity against human A549 cells after 96 hrs by MTT assay
    Cytotoxicity against human A549 cells after 96 hrs by MTT assay
    [PMID: 17125236]
    BGC-823 IC50
    > 10 μg/mL
    Compound: page 1629, R25C1
    Cytotoxicity against human BGC-823 cells after 96 hrs by MTT assay
    Cytotoxicity against human BGC-823 cells after 96 hrs by MTT assay
    [PMID: 17125236]
    BMDC IC50
    > 50 μM
    Compound: 16
    Inhibition of LPS-induced IL-12 p40 production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA
    Inhibition of LPS-induced IL-12 p40 production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA
    [PMID: 25769817]
    BMDC IC50
    > 50 μM
    Compound: 16
    Inhibition of LPS-induced IL-6 production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA
    Inhibition of LPS-induced IL-6 production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA
    [PMID: 25769817]
    BMDC IC50
    > 50 μM
    Compound: 16
    Inhibition of LPS-induced TNF-alpha production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA
    Inhibition of LPS-induced TNF-alpha production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA
    [PMID: 25769817]
    BV-2 IC50
    26.11 μM
    Compound: 170
    Antiinflammatory activity against mouse BV-2 cells assessed as reduction in LPS induced NO production measured for 24 hrs by Griess reagent based analysis
    Antiinflammatory activity against mouse BV-2 cells assessed as reduction in LPS induced NO production measured for 24 hrs by Griess reagent based analysis
    [PMID: 37683361]
    BV-2 IC50
    9.52 μM
    Compound: 12
    Antineuroinflammatory activity in human BV2 cells assessed as inhibition of LPS-induced NO production after 24 hrs in presence of LPS by Griess reaction
    Antineuroinflammatory activity in human BV2 cells assessed as inhibition of LPS-induced NO production after 24 hrs in presence of LPS by Griess reaction
    [PMID: 27623545]
    Bel-7402 IC50
    > 10 μg/mL
    Compound: page 1629, R25C1
    Cytotoxicity against human Bel-7402 cells after 96 hrs by MTT assay
    Cytotoxicity against human Bel-7402 cells after 96 hrs by MTT assay
    [PMID: 17125236]
    H9 EC50
    > 345 μM
    Compound: 20
    Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 3 days by p24 antigen capture assay
    Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 3 days by p24 antigen capture assay
    [PMID: 8158164]
    H9 IC50
    > 345 μM
    Compound: 20
    Cytotoxicity against human H9 cells after 3 days
    Cytotoxicity against human H9 cells after 3 days
    [PMID: 8158164]
    HCT-8 ED50
    > 10 μg/mL
    Compound: 46
    Cytotoxicity against human HCT8 cells by tetrazolium salt-based colorimetric assay
    Cytotoxicity against human HCT8 cells by tetrazolium salt-based colorimetric assay
    [PMID: 1431932]
    HCT-8 IC50
    > 10 μg/mL
    Compound: page 1629, R25C1
    Cytotoxicity against human HCT8 cells after 96 hrs by MTT assay
    Cytotoxicity against human HCT8 cells after 96 hrs by MTT assay
    [PMID: 17125236]
    KB ED50
    > 10 μg/mL
    Compound: 46
    Cytotoxicity against human KB cells by tetrazolium salt-based colorimetric assay
    Cytotoxicity against human KB cells by tetrazolium salt-based colorimetric assay
    [PMID: 1431932]
    MT4 CC50
    86.8 μg/mL
    Compound: 12
    Cytotoxicity against human MT4 cells by MTT assay
    Cytotoxicity against human MT4 cells by MTT assay
    [PMID: 10425115]
    MT4 IC50
    > 86.8 μg/mL
    Compound: 12
    Antiviral activity against HIV infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay
    Antiviral activity against HIV infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay
    [PMID: 10425115]
    Platelet IC50
    27.65 μg/mL
    Compound: (+)-Catechin
    Antiaggregatory activity in human platelets assessed as inhibition of collagen-induced platelet aggregation by aggregometry
    Antiaggregatory activity in human platelets assessed as inhibition of collagen-induced platelet aggregation by aggregometry
    [PMID: 21106454]
    Platelet IC50
    > 50 μg/mL
    Compound: (+)-Catechin
    Antiaggregatory activity in human platelets assessed as inhibition of thrombin-induced platelet aggregation by aggregometry
    Antiaggregatory activity in human platelets assessed as inhibition of thrombin-induced platelet aggregation by aggregometry
    [PMID: 21106454]
    TE-671 ED50
    > 10 μg/mL
    Compound: 46
    Cytotoxicity against human TE671 cells by tetrazolium salt-based colorimetric assay
    Cytotoxicity against human TE671 cells by tetrazolium salt-based colorimetric assay
    [PMID: 1431932]
    In Vitro

    Catechin ((+)-Catechin) exhibits >95% inhibitory activity at 70 μg/mL against cyclooxygenase-1 (COX-1) with an IC50 of 1.4 μM[1].
    A dose-dependent reduction in color is observed after 24 hours of treatment with Catechin, and 54.76% of the cells are dead at the highest concentration of Catechin tested (160 μg/mL) whereas the IC50 of Catechin is achieved at 127.62 μg/mL Catechin. A dose- and time-dependent increase in the induction of apoptosis is observed when MCF-7 cells are treated with Catechin. When compare to the control cells at 24 hours, 40.7 and 41.16% of the cells treated with 150 μg/mL and 300 μg/mL Catechin, respectively, undergo apoptosis. The expression levels of Caspase-3, -8, and -9 and p53 in MCF-7 cells treated with 150 μg/mL Catechin for 24 h increase by 5.81, 1.42, 3.29, and 2.68 fold, respectively, as compare to the levels in untreated control cells[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    In Vivo

    Animals treated with Catechin ((+)-Catechin) at the lowest tested dose, i.e., 50 mg/kg, p.o. have spent comparatively more time in exploring the novel object in the choice trial, however, the difference is not statistically significant. Catechin prevents the time-induced episodic memory deficits in a dose-dependent manner, the most effective being 200 mg/kg, p.o.. Treatment with Catechin prevents the rise in MPO level compare to DOX alone treatment group (21.98±9.44 and 36.76±4.39% in the hippocampus and the frontal cortex respectively)[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Molecular Weight

    290.27

    Formula

    C15H14O6

    CAS No.
    Appearance

    Solid

    Color

    Yellow to brown

    SMILES

    O[C@@H]1[C@@H](C2=CC(O)=C(O)C=C2)OC3=CC(O)=CC(O)=C3C1

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage

    4°C, sealed storage, away from moisture and light

    *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

    Solvent & Solubility
    In Vitro: 

    DMSO : 100 mg/mL (344.51 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    H2O : 12.5 mg/mL (43.06 mM; Need ultrasonic)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 3.4451 mL 17.2253 mL 34.4507 mL
    5 mM 0.6890 mL 3.4451 mL 6.8901 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.5 mg/mL (8.61 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.5 mg/mL (8.61 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

    *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 99.30%

    References
    Cell Assay
    [2]

    The Cell viability assay is performed to assess the toxicity of different concentrations of Catechin on MCF-7 cells. Briefly, MCF-7 cells (2×104 cells/well) are plated in 96-well plates and treated with 0 μg/mL Catechin and 160 μg/mL Catechin for 24 hours. Then, 40 μL of the Cell Titer Blue solution is directly added to the wells and incubated at 37°C for 6 hours. The fluorescence is recorded with a 560 nm/590 nm (excitation/emission) filter set using a microplate fluorescence reader, and the IC50 is calculated. Quadruplet samples are run for each concentration of Catechin in three independent experiments[2].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Administration
    [3]

    Rats[3]
    Twelve weeks old, healthy male rats weighing 200 to 230 g are used in this study. Rats are divided into four experimental groups (n=9 each) for one vehicle and three groups of Catechin (three doses). The doses of Catechin are prepared at 50, 100, 200 mg/kg in 0.25% w/v sodium carboxy methylcellulose (CMC) and administered orally for 7 days prior to and during the experimental trials. Episodic memory, the conscious memory of the past experiences is evaluated in this study[3].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    H2O / DMSO 1 mM 3.4451 mL 17.2253 mL 34.4507 mL 86.1267 mL
    5 mM 0.6890 mL 3.4451 mL 6.8901 mL 17.2253 mL
    10 mM 0.3445 mL 1.7225 mL 3.4451 mL 8.6127 mL
    15 mM 0.2297 mL 1.1484 mL 2.2967 mL 5.7418 mL
    20 mM 0.1723 mL 0.8613 mL 1.7225 mL 4.3063 mL
    25 mM 0.1378 mL 0.6890 mL 1.3780 mL 3.4451 mL
    30 mM 0.1148 mL 0.5742 mL 1.1484 mL 2.8709 mL
    40 mM 0.0861 mL 0.4306 mL 0.8613 mL 2.1532 mL
    DMSO 50 mM 0.0689 mL 0.3445 mL 0.6890 mL 1.7225 mL
    60 mM 0.0574 mL 0.2871 mL 0.5742 mL 1.4354 mL
    80 mM 0.0431 mL 0.2153 mL 0.4306 mL 1.0766 mL
    100 mM 0.0345 mL 0.1723 mL 0.3445 mL 0.8613 mL

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Catechin
    Cat. No.:
    HY-N0898
    Quantity:
    MCE Japan Authorized Agent: